From Name:
From Email:
To Name:
To Email:

Optional Message:


Studies cite benefits of tavaborole for onychomycosis

from Podiatry Today

Two recent phase III studies point to a new topical agent as an effective treatment option for onychomycosis. The studies, published in the Journal of the American Academy of Dermatology, focused on the use of tavaborole (Kerydin, PharmaDerm) for adults with distal subungual onychomycosis affecting 20 to 60 percent of a great toenail. By a 2:1 ratio, patients received either tavaborole or a vehicle treatment once a day for 48 weeks. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063